Omega-3s are one of the few supplements with consistent evidence for reducing inflammatory joint symptoms – but the benefit is dose-dependent, condition-specific, and often smaller than marketing suggests.
Omega-3 supplementation – particularly EPA – reduces systemic inflammatory markers and has meaningful evidence for reducing joint pain in rheumatoid arthritis (RA) and osteoarthritis (OA). A 2012 meta-analysis of 17 RCTs found omega-3 supplementation significantly reduced joint pain intensity, morning stiffness, number of painful joints, and NSAID consumption in RA patients. Effects in OA are smaller but present – a 2015 trial found high-dose DHA+EPA (3 g/day) reduced knee OA pain as effectively as celecoxib in a 24-week comparison. Omega-3’s joint benefits work through reducing arachidonic acid cascade inflammation (prostaglandins, leukotrienes) rather than direct analgesic mechanisms – effects build over 6-12 weeks of consistent use.
Sources
- A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain. 2007. PMID: 17335973.
- Session 3: Joint Nutrition Society and Irish Nutrition and Dietetic Institute Symposium on ‘Nutrition and autoimmune disease’ PUFA, inflammatory processes and rheumatoid arthritis. The Proceedings of the Nutrition Society. 2008. PMID: 18847518.
- Evaluation of nutritional interventions and their impact on metabolic syndrome risk markers in older adults. Frontiers in nutrition. 2026. PMID: 41867670.
- Impact of Mediterranean diet adherence on quality of life in patients with multiple sclerosis: A prospective study. Clinical nutrition ESPEN. 2026. PMID: 41698479.
Leave a Reply